GLOBAL MEDICAL REIT INC (GMRE) Stock Earnings & Estimates
NYSE:GMRE - US37954A2042 - REIT
7.33 USD
+0.33 (+4.71%)
7.37 USD
+0.04 (+0.55%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 137.3M 18.46% | 141.049M 2.73% | 138.78M -1.61% | 149.43M 7.67% | 155.47M 4.04% | 165.76M 6.62% | 162.55M -1.94% | |
| EBITDA YoY % growth | 95.44M 13.63% | 95.936M 0.52% | 87.96M -8.31% | 99.357M 12.96% | 103.96M 4.63% | 106.9M 2.83% | 107.92M 0.95% | |
| EBIT YoY % growth | 38.8M 4.30% | 37.979M -2.12% | 33.047M -12.99% | 38.621M 16.87% | 40.805M 5.65% | 44.982M 10.24% | 47.328M 5.22% | |
| Operating Margin | 28.26% | 26.93% | 23.81% | 25.85% | 26.25% | 27.14% | 29.12% | |
| EPS YoY % growth | 0.20 5.26% | 0.23 15.00% | 0.04 -82.61% | 0.07 70.01% | 0.07 4.99% | 0.07 -7.14% | 0.09 38.46% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 -66.00% | 0.03 -49.00% | 0.01 -66.00% | 0.01 202.00% | 0.01 | 0.02 -20.00% | 0.01 | 0.01 | 0.02 100.00% | 0.02 |
| Revenue Q2Q % growth | 38.927M 13.61% | 38.729M 10.16% | 39.309M 13.55% | 39.912M 5.12% | 39.878M 2.44% | 40.158M 3.69% | 43.858M 11.57% | 44.605M 11.76% | 45.351M 13.72% | 46.097M 14.79% |
| EBITDA Q2Q % growth | 26.642M -46.94% | 26.99M -56.13% | 27.504M 18.65% | 27.873M -24.86% | 28.388M 6.55% | 28.686M 6.28% | 30.134M 9.56% | 30.719M 10.21% | 31.051M 9.38% | 31.636M 10.28% |
| EBIT Q2Q % growth | 9.055M 2.85% | 9.426M 42.49% | 9.883M 3.10% | 10.011M 18.66% | 10.67M 17.84% | 10.541M 11.83% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.01 80.00% | 0.03 | -0.04 | -132.68% |
| Q1 2025 Q2Q % growth | 0.03 200.00% | 0.01 | 0.02 | 135.29% |
| Q4 2024 Q2Q % growth | 0.05 600.00% | 0.00 | 0.05 | % |
| Q3 2024 Q2Q % growth | 0.03 -40.00% | 0.02 | 0.01 | 26.07% |
| Q2 2024 Q2Q % growth | -0.05 -127.78% | 0.00 | -0.05 | % |
| Q1 2024 Q2Q % growth | 0.01 | 0.00 | 0.01 | 194.41% |
| Q4 2023 Q2Q % growth | -0.01 -200.00% | 0.02 | -0.03 | -165.36% |
| Q3 2023 Q2Q % growth | 0.05 -58.33% | 0.01 | 0.04 | 250.14% |
| Q2 2023 Q2Q % growth | 0.18 500.00% | 0.02 | 0.16 | 1,076.47% |
| Q1 2023 Q2Q % growth | 0.01 -75.00% | 0.02 | -0.01 | -34.64% |
| Q4 2022 Q2Q % growth | 0.01 -83.33% | 0.03 | -0.02 | -64.35% |
| Q3 2022 Q2Q % growth | 0.12 100.00% | 0.04 | 0.08 | 226.80% |
| Q2 2022 Q2Q % growth | 0.03 -25.00% | 0.05 | -0.02 | -38.08% |
| Q1 2022 Q2Q % growth | 0.04 33.33% | 0.05 | -0.01 | -26.47% |
| Q4 2021 Q2Q % growth | 0.06 200.00% | 0.07 | -0.01 | -13.49% |
| Q3 2021 Q2Q % growth | 0.06 50.00% | 0.06 | 0.00 | 6.95% |
| Q2 2021 Q2Q % growth | 0.04 | 0.05 | -0.01 | -18.30% |
| Q1 2021 Q2Q % growth | 0.03 | 0.04 | -0.01 | -15.97% |
| Q4 2020 Q2Q % growth | 0.02 -33.33% | 0.04 | -0.02 | -50.98% |
| Q3 2020 Q2Q % growth | 0.04 100.00% | -0.12 | 0.16 | 132.14% |
| Q2 2020 Q2Q % growth | 0.00 -100.00% | 0.03 | -0.03 | -100.00% |
| Q1 2020 Q2Q % growth | 0.03 50.00% | 0.04 | -0.01 | -19.79% |
| Q4 2019 Q2Q % growth | 0.03 | 0.05 | -0.02 | -36.06% |
| Q3 2019 Q2Q % growth | 0.02 | 0.03 | -0.01 | -38.73% |
| Q2 2019 Q2Q % growth | 0.03 | 0.06 | -0.03 | -48.10% |
| Q1 2019 Q2Q % growth | 0.02 | 0.02 | 0.00 | -12.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 37.969M 10.89% | 36.08M | 1.889M | 5.24% |
| Q1 2025 Q2Q % growth | 34.618M -1.42% | 36.089M | -1.471M | -4.08% |
| Q4 2024 Q2Q % growth | 35.157M 6.66% | 35.32M | -163K | -0.46% |
| Q3 2024 Q2Q % growth | 34.264M -3.50% | 35.338M | -1.074M | -3.04% |
| Q2 2024 Q2Q % growth | 34.241M -5.80% | 35.125M | -884K | -2.52% |
| Q1 2024 Q2Q % growth | 35.118M -3.07% | 34.617M | 501K | 1.45% |
| Q4 2023 Q2Q % growth | 32.962M -9.22% | 36.353M | -3.391M | -9.33% |
| Q3 2023 Q2Q % growth | 35.507M 0.27% | 36.72M | -1.213M | -3.30% |
| Q2 2023 Q2Q % growth | 36.351M 7.87% | 37.021M | -670K | -1.81% |
| Q1 2023 Q2Q % growth | 36.23M 13.64% | 37.347M | -1.117M | -2.99% |
| Q4 2022 Q2Q % growth | 36.31M 19.68% | 36.669M | -359K | -0.98% |
| Q3 2022 Q2Q % growth | 35.41M 18.11% | 35.424M | -14K | -0.04% |
| Q2 2022 Q2Q % growth | 33.7M 19.25% | 33.457M | 243K | 0.73% |
| Q1 2022 Q2Q % growth | 31.88M 16.56% | 32.058M | -178K | -0.56% |
| Q4 2021 Q2Q % growth | 30.34M 21.70% | 31.235M | -895K | -2.87% |
| Q3 2021 Q2Q % growth | 29.98M 19.44% | 29.875M | 105K | 0.35% |
| Q2 2021 Q2Q % growth | 28.26M 28.11% | 29.204M | -944K | -3.23% |
| Q1 2021 Q2Q % growth | 27.35M 26.33% | 26.277M | 1.073M | 4.08% |
| Q4 2020 Q2Q % growth | 24.93M 21.91% | 26.12M | -1.19M | -4.56% |
| Q3 2020 Q2Q % growth | 25.1M 37.91% | 23.137M | 1.963M | 8.48% |
| Q2 2020 Q2Q % growth | 22.06M 30.69% | 22.344M | -284K | -1.27% |
| Q1 2020 Q2Q % growth | 21.65M 42.43% | 21.68M | -30K | -0.14% |
| Q4 2019 Q2Q % growth | 20.45M | 19.87M | 580K | 2.92% |
| Q3 2019 Q2Q % growth | 18.2M | 18.1M | 100K | 0.55% |
| Q2 2019 Q2Q % growth | 16.88M | 16.93M | -50K | -0.30% |
| Q1 2019 Q2Q % growth | 15.2M | 15.321M | -121K | -0.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -69.23% | -66.67% | -42.53% | -4.76% |
| Revenue | 6.92% | 4.66% | 3.08% | 3.08% |